Acura actively pursues patents and trademark protection for our business interests. In addition to our issued U.S. patents, we have filed multiple U.S. patent applications and international patent applications relating to compositions containing abusable active pharmaceutical ingredients as well as applications covering our IMPEDE® and LIMITX Technologies. Acura has retained all intellectual property rights to our technologies and related product candidates.

Reference is made to the Risk Factors link on this web site and contained in our filings with the Securities and Exchange Commission for a discussion, among other things, of patent applications and patents owned by third parties including claims that may encompass our AVERSION® Technology and Oxaydo® tablets.

To view a current listing of all issued patents and patent applications, please select the most recent 10-Q or 10-K Report.